Metformin Exhibits Anti‐Inflammatory Effects by Regulating microRNA‐451/CXCL16 and B Cell Leukemia/Lymphoma 2 in Patients With Osteoarthritis

Documenti analoghi

• Exploring microRNA pathways and metformin’s anti‐inflammatory potential in osteoarthritis
  di: Quang D. La, et al.
  Pubblicazione: (2025)
• Identification of miR‐190a‐5p and miR‐26b‐5p as Potential microRNA Biomarkers for Psoriatic Arthritis
  di: Omar F. Cruz‐Correa, et al.
  Pubblicazione: (2025)
• Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis
  di: Yurilu A. Gonzalez Moret, et al.
  Pubblicazione: (2024)
• The Relationship Between Anti–Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti‐Sp4 Autoantibodies, and Cancer in Anti–Transcription Intermediary Factor 1γ–Positive Dermatomyositis
  di: Christopher A. Mecoli, et al.
  Pubblicazione: (2024)
• Duration of Disease and Long‐Term Outcomes in Patients With Difficult‐To‐Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti‐Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin‐1 Agents
  di: Elisa Ceriani, et al.
  Pubblicazione: (2025)